Introduction
Pelvic floor disorders (PFDs) are major health problems that can significantly compromise quality of life for affected women. In especially postmenopausal women, PFDs are important issues with heart disease, osteoporosis, and Alzheimer' s disease. 1, 2 Almost 24% of women are reported to be living with at least one PFD such as urinary incontinence (UI), fecal incontinence (FI) and pelvic organ prolapse (POP). 3~5 The female pelvic floor is composed of the levator ani and coccygeus skeletal muscles. These muscles function together to support the visceral contents of the abdominal cavity through sophisticated relationships between ligamentous connective tissue and skeletal muscles. Skeletal and smooth muscles are involved in the function and support of all pelvic viscera. 6 Pelvic floor muscle weakness is clinically vaginal bulge or protrusion, 8 involuntary leakage of urine, flatus or feces. 3 Causes of PFD are most likely multifactorial.
PFD has previously been associated with age, 9 pregnancy, 10 childbirth, 11 hysterectomy, 12 obesity, 11, 13, 14 race, 14 functional impairment, and cognitive impairment. 10 Vitamin D is a fat-soluble micronutrient that plays a vital role in calcium and phosphate homeostasis in smooth and skeletal muscle. 15, 16 Vitamin D levels are determined by many factors, such as skin pigmentation, geographic location, and body mass index (BMI 
Genotyping
Genomic DNA was extracted from ethylenediamine-tetraceticacid (EDTA) whole blood using a salting-out procedure. Genotyping of the following VDR gene polymorphisms was performed using a QIAamp DNA Blood Mini Kit (Qiagen, Inc., Valencia, CA, USA): ApaI (rs7975232), TaqI (rs731236), FokI (rs2228570) and BsmI (rs1544410). These polymorphisms were named after the restriction enzyme that have traditionally been used for their detection. 24 The VDR gene polymorphisms were analyzed using polymerase chain reaction-restriction fragment length polymorphism analysis.
Statistical analysis
Data were analyzed with significance determined at P < (Fig. 1) . Of the remaining 134 women, 47 cases had PFD symptoms, and 87 controls had no PFD symptoms.
Each group was further sub-categorized according to vitamin D levels (deficient <20 ng/mL, insufficient 20-30 ng/ mL, and sufficient ≥30 ng/mL; Fig. 1 ). Table 1 documents the demographic characteristics comparing the cases and controls. There were no significant differences in age, BMI, parity, menopause status and mean serum total vitamin D levels between these 2 groups ( Table 1) .
Demographic characteristics

Vitamin D status and PFD symptoms
Our study aimed to identify whether vitamin D status was associated with PFD symptoms. The mean serum vitamin D level in the cases (13.01 ± 0.84) was not significantly different to that of the control group (15.11 ± 1.04) ( Table 1) .
However, there were significant differences between the case and control groups within vitamin D insufficient/deficient women (P < 0.05; Table 2 (Table 2) .
VDR genotypes and PFD symptoms
In the x 2 analysis between VDR polymorphisms and PFD, there were no significant differences in PFD diagnosis proportions between the cases and controls for the TaqI and FokI polymorphisms. However, the ApaI and BsmI polymorphisms were significantly associated with PFD in the vitamin D deficient and insufficient groups ( Table 3) . The cases showed an increased frequency of Aa genotype in the ApaI polymorphism compared to the frequency of the Aa genotype in this polymorphism in the controls (P < 0.05). 
Discussion
This study demonstrated that serum vitamin D status correlates inversely with the prevalence of PFD in women.
All women with PFD symptoms in this study were vitamin The Aa (ApaI) and bb (BsmI) genotype frequencies were higher in the cases than in the controls. To our knowledge, this is the first study to demonstrate an association between VDR gene polymorphisms and PFD. Although ApaI-composition of common population 34, 35 are more heterozygotes than homozygotes, we showed that 
